Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle

References

• RodeghieroFStasiRGernsheimerTStandardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood2009113112386239319005182
   PubMed Web of Science ®Google Scholar
• SchoonenWMKuceraGCoalsonJEpidemiology of immune thrombocytopenic purpura in the General Practice Research DatabaseBr J Haematol2009145223524419245432
   PubMed Web of Science ®Google Scholar
• CinesDBBusselJBLiebmanHAThe ITP syndrome: pathogenic and clinical diversityBlood200913266511652119395674
   PubMed Web of Science ®Google Scholar
• CortelazzoSFinazziGBuelliMHigh risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpuraBlood199177131331984800
   PubMed Web of Science ®Google Scholar
• RaifeTJOlsonJDLentzSRPlatelet antibody testing in idiopathic thrombocytopenic purpuraBlood1997893111211149028346
   PubMed Web of Science ®Google Scholar
• BrightonTAEvansSCastaldiPAProspective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopeniasBlood19968811942018704174
   PubMed Web of Science ®Google Scholar
• KiefelVSantosoSWeisheitMMonoclonal antibody – specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodiesBlood1987706172217262445398
   PubMed Web of Science ®Google Scholar
• ProvanDStasiRNewlandACInternational consensus report on the investigation and management of primary immune thrombocytopeniaBlood2010115216818619846889
   PubMed Web of Science ®Google Scholar
• GeorgeJNWoolfSHRaskobGEIdiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of HematologyBlood19968813408704187
   PubMed Web of Science ®Google Scholar
• DavorenABusselJCurtisBRProspective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP)Am J Hematol200578319319715726595
   PubMed Web of Science ®Google Scholar
• McMillanRWangLTaniPProspective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP)J Thromb Haemost20031348549112871454
   PubMed Web of Science ®Google Scholar
• RoarkJHBusselJBCinesDBGenetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutationBlood200210041388139812149222
   PubMed Web of Science ®Google Scholar
• van LeeuwenEFvan der VenJTEngelfrietCPSpecificity of autoantibodies in autoimmune thrombocytopeniaBlood198259123267032627
   PubMed Web of Science ®Google Scholar
• HeRReidDMJonesCESpectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpuraBlood1994834102410328111044
   PubMed Web of Science ®Google Scholar
• FujisawaKTaniPO’TooleTEDifferent specificities of plateletassociated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic immune thrombocytopenic purpuraBlood1992796144114461547343
   PubMed Web of Science ®Google Scholar
• SempleJWMilevYCosgraveDDifferences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivityBlood19968710424542548639783
   PubMed Web of Science ®Google Scholar
• LingYCaoXYuZCirculating dendritic cells subsets and CD4+ Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasomeEur J Haematol200779431031617692100
   PubMed Web of Science ®Google Scholar
• Heyns AduPBadenhorstPNLötterMGPlatelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differBlood198667186923940554
   PubMed Web of Science ®Google Scholar
• BallemPJSegalGMStrattonJRMechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearanceJ Clin Invest198780133403597777
   PubMed Web of Science ®Google Scholar
• KosugiSKurataYTomiyamaYCirculating thrombopoietin level in chronic immune thrombocytopenic purpuraBr J Haematol19969337047068652398
   PubMed Web of Science ®Google Scholar
• MukaiHYKomjimaHTodokoroKSerum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpuraThromb Haemost19967656756788950771
   PubMed Web of Science ®Google Scholar
• SchrezenmeierHGriesshammerMHornkohlAThrombopoetin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remissionBr J Haematol199810035715769504643
   PubMed Web of Science ®Google Scholar
• BroudyVCLinNLSabathDFHuman platelets display highaffinity receptors for thrombopoietinBlood1997896189619049058709
   PubMed Web of Science ®Google Scholar
• LiJXiaJKuterDJInteraction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokineticsBr J Haematol1999106234535610460590
   PubMed Web of Science ®Google Scholar
• AledortLMHaywardCPChenMGProspective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodiesAm J Hematol200476320521315224353
   PubMed Web of Science ®Google Scholar
• HiyoyamaKWadaHShimuraMIncreased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulationBlood Coagul Fibrinolysis1997863453499351524
   PubMed Web of Science ®Google Scholar
• UsukiKTaharaTIkiSSerum thrombopoietin level in various hematological diseasesStem Cells19961455585658888496
   PubMed Web of Science ®Google Scholar
• GernsheimerTStrattonJBallemPJMechanisms of response to treatment in autoimmune thrombocytopenic purpuraN Engl J Med1989320159749802927480
   PubMed Web of Science ®Google Scholar
• HouwerzijlEJLouwesHSluiterWJPlatelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpuraAnn Hematol2008871297598318690441
   PubMed Web of Science ®Google Scholar
• RodeghieroFFirst-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treatEur J Haematol Suppl200869192618211569
   PubMedGoogle Scholar
• StasiRStipaEMasiMLong-term observation of 208 adults with chronic idiopathic thrombocytopenic purpuraAm J Med19959854364427733121
   PubMed Web of Science ®Google Scholar
• MazzucconiMGFaziPBernasconiSTherapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experienceBlood200710941401140717077333
   PubMed Web of Science ®Google Scholar
• GeorgeJNVeselySKHow can we provide the best care for our patients with immune thrombocytopenic pupura?Mayo Clin Proc200479445645715065609
   PubMed Web of Science ®Google Scholar
• ChengYWongRSSooYOInitial treatment of immune thrombocytopenic purpura with high-dose dexamethasoneN Engl J Med2003349983183612944568
   PubMed Web of Science ®Google Scholar
• WangBNicholJLSullivanJTPharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligandClin Pharmacol Ther200476662863815592334
   PubMed Web of Science ®Google Scholar
• KuterDBusselJBLyonsBEfficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialLancet2008371961039540318242413
   PubMed Web of Science ®Google Scholar
• Erickson-MillerCDeLormeETianSDiscovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonistExp Hematol2005331859315661401
   PubMed Web of Science ®Google Scholar
• JenkinsJMWilliamsDDengPhase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonistBlood2007109114739474117327409
   PubMed Web of Science ®Google Scholar
• BusselJBChengGSalehMNEltrombopag for the treatment of chronic idiopathic thrombocytopenic purpuraN Engl J Med2007357222237224718046028
   PubMed Web of Science ®Google Scholar
• BusselJBProvanDShamsiTEffect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trialLancet2009373966464164819231632
   PubMed Web of Science ®Google Scholar
• ColumbyovaLLodaMScaddenDTThrombopoietin receptor expression in human cancer cell lines and primary tissuesCancer Res19955516350935127627956
   PubMed Web of Science ®Google Scholar
• KantarjianHSekeresMAPhase 1/2 study of AMG 531 in thrombocytopenic patients with low-risk myelodysplastic syndrome: update including extended treatment [abstract]Blood2007110: Abstract 250.
   Web of Science ®Google Scholar
• SchwartzJLeberMDGillisSMLong term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)Am J Hematol2003722949812555211
   PubMed Web of Science ®Google Scholar
• CinesDBBusselJBHow I treat idiopathic thrombocytopenic purpura (ITP)Blood200510672244225115941913
   PubMed Web of Science ®Google Scholar
• FabrisFTassanTRamonRAge as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpuraBr J Haematol2001112363764011260065
   PubMed Web of Science ®Google Scholar
• BourgeoisECaulierMTDelarozeeCLong-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysisBr J Haematol200312061079108812648082
   PubMed Web of Science ®Google Scholar
• BusselJBCinesDBIdiopathic thrombocytopenic purpura, neonatal alloimmune thrombocytopenia, and post-transfusion purpuraHoffmanRBenzEJJrShattilSJHematology: Basic Principles and PracticePhiladelphia, PAChurchill Livingstone200020962114
   Google Scholar
• KojouriKVeselySKDeirdraRSplenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complicationsBlood200410492623263415217831
   PubMed Web of Science ®Google Scholar
• LortanJEManagement of asplenic patientsBr J Haematol19938445665698217814
   PubMed Web of Science ®Google Scholar
• BusselJBPhamLCIntravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literatureVox Sang19875232062112440183
   PubMed Web of Science ®Google Scholar
• AgnelliGDeCuntoMGreselePVincristine-loaded platelets for autoimmune thrombocytopenic purpuraBlood198260512356889900
   PubMed Web of Science ®Google Scholar
• StasiRPaganoAEtipaERituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpuraBlood200198495295711493438
   PubMed Web of Science ®Google Scholar
• CooperNHeddleNMHaasMIntravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphismsBr J Haematol2004124451151814984503
   PubMed Web of Science ®Google Scholar
• QuiquandonFPCaulierMTPagniezDRe-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 casesBr J Haematol19907422232282317458
   PubMed Web of Science ®Google Scholar
• ProvanDNewlandAFifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adultsBr J Haematol2002118493394412199770
   PubMed Web of Science ®Google Scholar